Flax Pond Capital’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
Other funds holding GPCR
BBA
Flax Pond Capital's GPCR Position: Q3 2026 in Review
Flax Pond Capital reduced its Structure Therapeutics (GPCR) stake by 51% in Q3 2026, selling an estimated $859K and leaving 17,688 shares worth $553K. The position accounts for 0.39% of the portfolio, ranked #49.
Flax Pond Capital first reported a position in GPCR in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.39M in Q4 2025. 172 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.
- Flax Pond Capital held 17,688 shares of Structure Therapeutics worth $553K as of Q3 2026.
- Flax Pond Capital sold 18,312 Structure Therapeutics shares in Q3 2026, an estimated $859K.
- Structure Therapeutics made up 0.39% of Flax Pond Capital's portfolio in Q3 2026, its #49 holding.
- Flax Pond Capital first reported a position in Structure Therapeutics in Q4 2025 and has held it in 4 quarters since.
- Flax Pond Capital's Structure Therapeutics position peaked at $3.39M in Q4 2025.
- 172 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.
Based on Flax Pond Capital's 13F filing for Q3 2026, filed 18 Nov 2026.